HHS Announces “Safe” Drug Importation Plan

The U.S. Department of Health and Human Services (HHS) announced this week that it and the FDA are publishing a Safe Importation Action Plan with two pathways for drug importation of certain drugs from foreign markets.  HHS Secretary Alex Azar stated that this “announcement outlines the pathways the Administration intends to explore to allow safe […]

National Pharmacy Organizations Write Azar Regarding Drug Importation

NASPA, along with the American Pharmacists Association (APhA) and the National Association of Chain Drug Stores (NACDS), wrote U.S. Department of Health and Human Services Secretary Azar this week regarding state prescription drug importation plans.  All three organizations oppose the approval of a state drug importation program that meets a lower standard than that set […]

Over 100 Organizations Urge Congress to Oppose Importation of Non-FDA Approved Drugs

Over 100 health, patient advocacy, and law enforcement organizations, including NASPA and state pharmacy associations, signed on to a letter sent to President Trump and members of Congress asking them to safeguard patients and protect the secure U.S. prescription drug supply.  The letter reminds the president and members of Congress that four previous FDA commissioners […]

APhA’s Comments on the Importation of Non-FDA Approved Drugs

The American Pharmacists Association (APhA) submitted comments to Congress in March 2017 on the importation of non-FDA approved prescription drugs. APhA stated in the letter that they  “believe proposals to legalize importation of non-FDA approved drugs is in direct conflict with recent efforts by Congress and federal agencies to increase the integrity and security of the […]